483
I3 PHARMACEUTICALS LLCFDA 483 - I3 PHARMACEUTICALS LLC - February 22, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of I3 PHARMACEUTICALS LLC in Warminster, PA, from February 7-22, 2022, revealed significant deficiencies in manufacturing and quality control. Observations included inadequate cleaning procedures and validation, insufficient environmental controls for temperature and humidity, and failures in quality assurance oversight. The firm also lacked thorough investigations into out-of-specification results and proper laboratory control mechanisms.
Open in Dashboard
ID · 49683585-7024-4621-8470-fe1abb46f124